The number of people with susceptibility test result for rifampicin in Argentina
Argentina: The number of people with susceptibility test result for rifampicin was 36.41 in 2021. ▲ Rising
Latest (2021)
36.41
Change on year
up 46.7%
World rank
127th
of 146 countries
All-time high
36.41
in 2021
All-time low
20.37
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Argentina, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Argentina is 36.41, measured in 2021. That is the highest value across all 5 years on record.
That represents a change of up 46.7% on the previous year and up 78.8% over five years.
That places Argentina 127th out of 146 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Argentina, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 20.37 | — |
| 2018 | 26.34 | +29.3% |
| 2019 | 20.4 | -22.6% |
| 2020 | 24.82 | +21.7% |
| 2021 | 36.41 | +46.7% |
Argentina compared with similar countries
- Argentina's 36.41 is below the median for upper middle income countries, which is 92.7, 39% of the median. (45 countries reporting)
- Argentina's 36.41 is below the median for Latin America & Caribbean, which is 59.38, 61% of the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 22.37 | 20.37 | 26.34 | 3 |
| 2020s | 30.62 | 24.82 | 36.41 | 2 |
Countries ranked near Argentina
More health data for Argentina
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6333 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,462 deaths per 1,000 people (2090)
- Number of infants who die before age 1 684 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.7 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0269 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.7 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Argentina?
- The number of people with susceptibility test result for rifampicin in Argentina was 36.41 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Argentina?
- The highest recorded value was 36.41 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Argentina?
- The lowest recorded value was 20.37 in 2017.
- How does Argentina rank for the number of people with susceptibility test result for rifampicin?
- Argentina ranks 127th out of 146 countries with data for 2021.
- Where does this Argentina data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).